Jovanović M, Džamić Z, Aćimović M, Kajmaković B, Pejčić T
Acta Chir Iugosl. 2014;61(1):57-61.
Laser therapy has gained increasing acceptance as a relatively less invasive treatment for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). From the early procedure of interstitial laser coagulation through to the use of holmium laser enucleation of the prostate, there has been an expanding body of evidence on the efficacy of such procedures. One of the newer lasers is the Green Light HPS 180 W laser. Studies with this GreenLight laser (GLL) (American Medical Systems, Inc, Minnetonka, MN, USA) showing results as good as those of transurethral resection of the prostate (TURP). In this paper, the efficacy of the new GLL 180-W versus the gold standard TURP in patients with LUTS due to BPH was tested in a prospective clinical trial.
To compare results of Green light laser (GLL) evaporisation of the prostatae and transurethral resection of the prostate (TURP) for treatment of BPH. MATERIJALS AND METHODS: A total of 62 patients with BPH were randomly assigned to two equal groups: TURP or GLL.
Both groups were compared regarding all relevant preoperative, operative, and postoperative parameters. Functional results in terms of improvement of International Prostate Symptom Score (IPSS), maximum flow rate (Qmax), and postvoid residual (PVR) urine were assessed at 1, 3, 6 and 12 mo. A total of 62 patients completed 12 mo of follow-up in the TURP and GLL groups, respectively. Baseline characteristics were comparable. Mean operative time was significantly shorter for TURP. Compared to preoperative values, there was significant reduction in hemoglobin levels at the end of TURP only. A significant difference in favor of GLL was achieved regarding the duration of catheterization and hospital stay. In the GLL, no major intraoperative complications were recorded and none of the patients required blood transfusion. Among TURP patients, 6 required transfusion, 1 developed TUR syndrome, and capsule perforation was observed in 5 patients. There was dramatic improvement in Qmax, IPSS, and GLL compared with preoperative values and the degree of improvement was comparable in both groups at all time points of follow-up. Four TURP patients and one GLL patients developed bladder neck contracture treated by bladder neck incision; none in either group experienced urethral stricture or urinary incontinence.
Compared to transurethral resection of the prostate, GreenLight HPS 180-W laser photoselective vaporization of the prostate is safe and effective in the treatment of patients suffering from lower urinary tract symptoms due to benign prostatic hyperplasia.
激光疗法作为一种治疗良性前列腺增生(BPH)所致下尿路症状(LUTS)的相对微创治疗方法,越来越被人们所接受。从早期的间质激光凝固术到钬激光前列腺剜除术,关于此类手术疗效的证据越来越多。新型激光之一是绿光HPS 180W激光。对这种绿光激光(GLL)(美国美敦力公司,美国明尼苏达州明尼通卡)的研究表明,其效果与经尿道前列腺切除术(TURP)相当。在本文中,通过一项前瞻性临床试验,对新型180W GLL与治疗BPH所致LUTS患者的金标准TURP的疗效进行了测试。
比较绿光激光(GLL)前列腺汽化术和经尿道前列腺切除术(TURP)治疗BPH的效果。材料与方法:总共62例BPH患者被随机分为两组,每组人数相等:TURP组或GLL组。
对两组患者所有相关的术前、术中及术后参数进行了比较。在术后1、3、6和12个月时,评估国际前列腺症状评分(IPSS)、最大尿流率(Qmax)和残余尿量(PVR)改善方面的功能结果。TURP组和GLL组分别共有62例患者完成了12个月的随访。基线特征具有可比性。TURP组的平均手术时间明显更短。与术前值相比,仅在TURP术后血红蛋白水平显著降低。在导尿时间和住院时间方面,GLL组有显著优势。在GLL组中,未记录到重大术中并发症,且无一例患者需要输血。在TURP组患者中,6例需要输血,1例发生TUR综合征,5例观察到包膜穿孔。与术前值相比,Qmax、IPSS和GLL均有显著改善,且在随访的所有时间点两组的改善程度相当。4例TURP患者和1例GLL患者发生膀胱颈挛缩,经膀胱颈切开治疗;两组均无患者发生尿道狭窄或尿失禁。
与经尿道前列腺切除术相比,绿光HPS 180W激光前列腺选择性汽化术治疗良性前列腺增生所致下尿路症状患者安全有效。